ONCAlert | 2017 San Antonio Breast Cancer Symposium

The Challenges in Using Immune Checkpoint Inhibitors to Treat Patients With Glioblastoma

David A. Reardon, MD
Published Online:4:26 PM, Wed July 13, 2016


David A. Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses the important considerations and challenges in using immune checkpoint inhibitors to treat patients with glioblastoma.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.